Ara-290 (16 mg Vial)

Ara-290 Research Information

Ara-290 information is provided for general educational and research reference only. This section presents general scientific background and research-related information.

Ara-290 (Cibinetide) is a synthetic peptide studied in scientific research contexts. Research has explored its biological characteristics and molecular properties across different areas of investigation. This educational overview provides general research background without medical guidance or specific usage information.

Educational overview for research reference and general information.

Standard Research Overview

Phase	Daily Blend (mg)	Volume (mL)
Week 1	2 mg (2,000 mcg)	25 units (0.25 mL)
Weeks 2–8 (or up to 16)	4 mg (4,000 mcg)	50 units (0.50 mL)

Frequency: General scientific observations and reference information are provided for educational and research purposes only. Research findings may vary depending on study design, methodology, and available documentation.

Research Information Steps

Important: This information is for educational purposes only and is provided for general research reference only.

Plan based on general research information and educational reference materials.

Concise summary of general research information based on available scientific references.

Goal: General information related to research concepts and scientific observations.
Schedule: Research findings may vary depending on study design, methodology, and available documentation.
Research Information: General scientific reference information is provided for educational and research purposes only.
Storage Information: Follow appropriate research material handling guidelines based on available documentation.

General overview of research-related information and scientific references.

General handling information is provided for research reference.

Practical considerations for consistency and research reference.

Use appropriate research material handling practices.
Maintain proper documentation and reference information.
Review available scientific information carefully.
Follow relevant research standards and guidelines.
Additional research observations may vary depending on study design and available documentation.

Ara-290 (Cibinetide) is a synthetic peptide studied in scientific research contexts. Research has explored its biological characteristics and molecular properties. Available studies examine different scientific aspects of Ara-290, and findings may vary depending on research methodology and available literature. This information is provided for general educational and research reference only.

Observations from preclinical and research literature.

Research Information: Scientific studies have explored Ara-290 in different research contexts.
Scientific Review: Available literature discusses various biological observations and research findings.
Research Context: Results may vary depending on study design, methodology, and available documentation.
General Note: Additional research information should be reviewed from relevant scientific sources.

Complementary strategies for general wellness and consistency.

Wellness: Maintain balanced lifestyle practices to support overall wellbeing.
Activity: Regular physical activity and healthy habits are commonly discussed in general wellness research.
Recovery: Prioritize quality sleep and stress management as part of a balanced routine.
Balance: Maintain healthy lifestyle habits for general wellness.

General research handling information from educational reference resources.

Handling: Follow appropriate research material handling guidelines.
Documentation: Maintain proper records and follow relevant research standards.
Reference: Review available scientific information for additional details.
Important: This content is provided for educational and research reference only.

General research information related to Ara-290 is provided for educational and research reference only.

Why Vitality Labs Peptides?

This content is intended for educational purposes only and is provided for general research reference only.

Explore related research information and background reading for Ara-290.

IUPHAR/BPS Guide to Pharmacology

— Cibinetide (ARA-290) ligand profile: structure, receptor binding, and pharmacology

Molecular Medicine (2008)

— Brines & Cerami: Discovery and development of the innate repair receptor and its non-erythropoietic ligands

Molecular Medicine (2014)

— Brines M. et al.: ARA 290 improves metabolic control and neuropathic symptoms in patients with type 2 diabetes

Molecular Medicine (2013)

— Dahan A. et al.: ARA 290 improves symptoms in Research Information Guide-associated small nerve fiber loss and increases corneal nerve fiber density

ClinicalTrials.gov (NCT02039687)

— Phase 2 study of ARA 290 on corneal nerve fiber density in Research Information Guide (1 mg vs 4 mg vs 8 mg daily SC for 28 days)

NCBI Bookshelf

— Stability and storage considerations for lyophilized peptide formulations

USP General Chapters

— Pharmaceutical compounding with bacteriostatic water: stability and beyond-use dating

Cleveland Clinic

Explore related research information and background reading for Ara-290.

Pain Reports (2017)

— Davis T. et al.: Targeting the innate repair receptor to treat neuropathy (review of ARA-290 mechanisms)

Investigative Ophthalmology & Visual Science (2016)

— Cibinetide improves corneal nerve fiber abundance in patients with Research Information Guide-associated small fiber neuropathy

Peptides Journal (2016)

— Zhang W. et al.: ARA 290 relieves pathophysiological pain by targeting TRPV1 channel

Johns Hopkins Arthritis Center

— General Research Information Reference

CDC

— Vaccine administration: subcutaneous route (angle, site, and technique guidance)

PMC Subcutaneous Drug Delivery Review

— General Research Information and Scientific Background

Vitality Lab Peptides

— Ara-290 General Research Reference and Background Information